北京中医药大学学报2023，Vol.46Issue(7)：897-901,5.DOI:10.3969/j.issn.1006-2157.2023.07.002
活血化瘀中药联合西医抗血小板药物在冠心病二级预防中的可能优势
The superiority of combining Chinese medicinals for promoting blood circulation and removing blood stasis with antiplatelet drugs in the secondary prevention of coronary heart disease
摘要
关键词
活血化瘀/中药/抗血小板药物/冠心病/二级预防Key words
promoting blood circulation for removing blood stasis/Chinese medicinals/antiplatelet drugs/coronary heart disease(CHD)/secondary prevention分类
医药卫生引用本文复制引用
史大卓..活血化瘀中药联合西医抗血小板药物在冠心病二级预防中的可能优势[J].北京中医药大学学报,2023,46(7):897-901,5.基金项目
国家中医药管理局中医药创新团队及人才支持计划项目(No.ZYYCXTD-C-202007) Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(No.ZYYCXTD-C-202007) （No.ZYYCXTD-C-202007）
